Biosurgery Market Size, Trends, Analysis, and Outlook By Product (Bone Graft Substitutes, Soft-tissue attachments, Hemostatic agents, Surgical sealants and adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, Others), by Country, Segment, and Companies, 2024-2032
The global Biosurgery market size is poised to register 7.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosurgery market across By Product (Bone Graft Substitutes, Soft-tissue attachments, Hemostatic agents, Surgical sealants and adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, Others)
The biosurgery market is driven by the increasing demand for advanced surgical technologies, innovations in biomaterials, and the need for biocompatible and bioresorbable surgical products. By 2030, the market is expected to witness significant growth, driven by advancements in hemostatic agents, surgical sealants, and soft tissue repair products. Further, expanding applications in wound closure, tissue regeneration, and minimally invasive surgery are anticipated to drive market expansion, enabling surgeons to achieve better outcomes, reduce postoperative complications, and enhance patient recovery.
Biosurgery Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biosurgery market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biosurgery survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biosurgery industry.
Key market trends defining the global Biosurgery demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biosurgery Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Biosurgery industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biosurgery companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biosurgery industry
Leading Biosurgery companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biosurgery companies.
Biosurgery Market Study- Strategic Analysis Review
The Biosurgery market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Biosurgery industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Biosurgery Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Biosurgery Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Biosurgery market segments. Similarly, Strong market demand is encouraging Canadian Biosurgery companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Biosurgery market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biosurgery Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biosurgery industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Biosurgery market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biosurgery Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biosurgery in Asia Pacific. In particular, China, India, and South East Asian Biosurgery markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Biosurgery Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biosurgery Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biosurgery market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biosurgery.
Biosurgery Market Company Profiles
The global Biosurgery market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson & Co., CSL Ltd, Cyrolife Inc, Hemostasis Llc, Integra Lifesciences Holdings Corp, Johnson & Johnson, Kuros Biosciences AG, Medtronic Plc, Orthofix Medical Inc , Pfizer Inc, Smiths & Nephew Plc., Stryker Corp, Zimmer Biomet Holdings Inc.
Recent Biosurgery Market Developments
The global Biosurgery market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biosurgery Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others
Geographical Segmentation:
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson & Co.
CSL Ltd
Cyrolife Inc
Hemostasis Llc
Integra Lifesciences Holdings Corp
Johnson & Johnson
Kuros Biosciences AG
Medtronic Plc
Orthofix Medical Inc
Pfizer Inc
Smiths & Nephew Plc.
Stryker Corp
Zimmer Biomet Holdings Inc
Formats Available: Excel, PDF, and PPT
The biosurgery market is driven by the increasing demand for advanced surgical technologies, innovations in biomaterials, and the need for biocompatible and bioresorbable surgical products. By 2030, the market is expected to witness significant growth, driven by advancements in hemostatic agents, surgical sealants, and soft tissue repair products. Further, expanding applications in wound closure, tissue regeneration, and minimally invasive surgery are anticipated to drive market expansion, enabling surgeons to achieve better outcomes, reduce postoperative complications, and enhance patient recovery.
Biosurgery Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biosurgery market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biosurgery survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biosurgery industry.
Key market trends defining the global Biosurgery demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biosurgery Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Biosurgery industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biosurgery companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biosurgery industry
Leading Biosurgery companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biosurgery companies.
Biosurgery Market Study- Strategic Analysis Review
The Biosurgery market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Biosurgery industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Biosurgery Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Biosurgery Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Biosurgery market segments. Similarly, Strong market demand is encouraging Canadian Biosurgery companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Biosurgery market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biosurgery Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biosurgery industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Biosurgery market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biosurgery Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biosurgery in Asia Pacific. In particular, China, India, and South East Asian Biosurgery markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Biosurgery Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biosurgery Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biosurgery market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biosurgery.
Biosurgery Market Company Profiles
The global Biosurgery market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson & Co., CSL Ltd, Cyrolife Inc, Hemostasis Llc, Integra Lifesciences Holdings Corp, Johnson & Johnson, Kuros Biosciences AG, Medtronic Plc, Orthofix Medical Inc , Pfizer Inc, Smiths & Nephew Plc., Stryker Corp, Zimmer Biomet Holdings Inc.
Recent Biosurgery Market Developments
The global Biosurgery market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biosurgery Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson & Co.
CSL Ltd
Cyrolife Inc
Hemostasis Llc
Integra Lifesciences Holdings Corp
Johnson & Johnson
Kuros Biosciences AG
Medtronic Plc
Orthofix Medical Inc
Pfizer Inc
Smiths & Nephew Plc.
Stryker Corp
Zimmer Biomet Holdings Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Biosurgery Market Overview and Key Findings, 2024
1.2 Biosurgery Market Size and Growth Outlook, 2021- 2030
1.3 Biosurgery Market Growth Opportunities to 2030
1.4 Key Biosurgery Market Trends and Challenges
1.4.1 Biosurgery Market Drivers and Trends
1.4.2 Biosurgery Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biosurgery Companies
2. BIOSURGERY MARKET SIZE OUTLOOK TO 2030
2.1 Biosurgery Market Size Outlook, USD Million, 2021- 2030
2.2 Biosurgery Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOSURGERY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOSURGERY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biosurgery Market, 2025
5.2 Asia Pacific Biosurgery Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biosurgery Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biosurgery Market, 2025
5.5 Europe Biosurgery Market Size Outlook by Type, 2021- 2030
5.6 Europe Biosurgery Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biosurgery Market, 2025
5.8 North America Biosurgery Market Size Outlook by Type, 2021- 2030
5.9 North America Biosurgery Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biosurgery Market, 2025
5.11 South America Pacific Biosurgery Market Size Outlook by Type, 2021- 2030
5.12 South America Biosurgery Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biosurgery Market, 2025
5.14 Middle East Africa Biosurgery Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biosurgery Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biosurgery Market Size Outlook and Revenue Growth Forecasts
6.2 US Biosurgery Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biosurgery Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biosurgery Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biosurgery Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biosurgery Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biosurgery Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biosurgery Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biosurgery Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biosurgery Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biosurgery Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biosurgery Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biosurgery Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biosurgery Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biosurgery Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biosurgery Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biosurgery Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biosurgery Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biosurgery Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biosurgery Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biosurgery Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biosurgery Industry Drivers and Opportunities
7. BIOSURGERY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOSURGERY COMPANY PROFILES
8.1 Profiles of Leading Biosurgery Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson & Co.
CSL Ltd
Cyrolife Inc
Hemostasis Llc
Integra Lifesciences Holdings Corp
Johnson & Johnson
Kuros Biosciences AG
Medtronic Plc
Orthofix Medical Inc
Pfizer Inc
Smiths & Nephew Plc.
Stryker Corp
Zimmer Biomet Holdings Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Biosurgery Market Overview and Key Findings, 2024
1.2 Biosurgery Market Size and Growth Outlook, 2021- 2030
1.3 Biosurgery Market Growth Opportunities to 2030
1.4 Key Biosurgery Market Trends and Challenges
1.4.1 Biosurgery Market Drivers and Trends
1.4.2 Biosurgery Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biosurgery Companies
2. BIOSURGERY MARKET SIZE OUTLOOK TO 2030
2.1 Biosurgery Market Size Outlook, USD Million, 2021- 2030
2.2 Biosurgery Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOSURGERY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOSURGERY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biosurgery Market, 2025
5.2 Asia Pacific Biosurgery Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biosurgery Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biosurgery Market, 2025
5.5 Europe Biosurgery Market Size Outlook by Type, 2021- 2030
5.6 Europe Biosurgery Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biosurgery Market, 2025
5.8 North America Biosurgery Market Size Outlook by Type, 2021- 2030
5.9 North America Biosurgery Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biosurgery Market, 2025
5.11 South America Pacific Biosurgery Market Size Outlook by Type, 2021- 2030
5.12 South America Biosurgery Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biosurgery Market, 2025
5.14 Middle East Africa Biosurgery Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biosurgery Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biosurgery Market Size Outlook and Revenue Growth Forecasts
6.2 US Biosurgery Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biosurgery Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biosurgery Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biosurgery Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biosurgery Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biosurgery Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biosurgery Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biosurgery Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biosurgery Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biosurgery Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biosurgery Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biosurgery Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biosurgery Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biosurgery Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biosurgery Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biosurgery Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biosurgery Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biosurgery Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biosurgery Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biosurgery Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biosurgery Industry Drivers and Opportunities
7. BIOSURGERY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOSURGERY COMPANY PROFILES
8.1 Profiles of Leading Biosurgery Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson & Co.
CSL Ltd
Cyrolife Inc
Hemostasis Llc
Integra Lifesciences Holdings Corp
Johnson & Johnson
Kuros Biosciences AG
Medtronic Plc
Orthofix Medical Inc
Pfizer Inc
Smiths & Nephew Plc.
Stryker Corp
Zimmer Biomet Holdings Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
